Table 1:

Characteristics of patients with evidence of injection drug use, comparing those with and without infective endocarditis

CharacteristicNo. (%) of patients*Standardized difference, %
Injection drug use without infective endocarditis
n = 59 796
Injection drug use with infective endocarditis
n = 733
Demographic data
Age at cohort entry, yr
 Mean ± SD, yr40.18 ± 10.7936.33 ± 9.4538
 Median (IQR), yr42 (31–50)36 (28–44)42
 18–257701 (12.9)99 (13.5)2
 26–3513 014 (21.8)256 (34.9)30
 36–4514 892 (24.9)230 (31.4)14
 46–5524 189 (40.5)148 (20.2)45
Sex, female26 324 (44.0)390 (53.2)18
Residential status
 Urban51 756 (86.6)640 (87.3)2
 Rural8011 (13.4)93 (12.7)2
 Missing29 (0.0)0 (0.0)3
Socioeconomic status
 1 (lowest)23 187 (38.8)320 (43.7)10
 212 876 (21.5)162 (22.1)1
 310 365 (17.3)113 (15.4)5
 47531 (12.6)77 (10.5)7
 5 (highest)5837 (9.8)61 (8.3)5
Comorbidities
 Alcohol abuse3658 (6.1)15 (2.0)21
 Bipolar disorder733 (1.2)< 67
 Chronic liver disease4220 (7.1)22 (3.0)19
 Depression and/or anxiety11 770 (19.7)120 (16.4)9
 Hepatitis B165 (0.3)0 (0.0)7
 Hepatitis C8609 (14.4)135 (18.4)11
 HIV2209 (3.7)46 (6.3)12
 Schizophrenia1065 (1.8)< 610
 Self-harm8244 (13.8)94 (12.8)3
Medication use
 Antibiotics14 544 (24.3)223 (30.4)14
 Anticoagulants590 (1.0)15 (2.0)9
 Antipsychotics9239 (15.5)94 (12.8)8
 Benzodiazepines12 909 (21.6)144 (19.6)5
 Lithium613 (1.0)< 67
 Opioids23 006 (38.5)366 (49.9)23
General measures of comorbidity
No. of unique drug prescriptions filled in 1 year
 Mean ± SD4.08 ± 5.593.85 ± 4.804
 Median (IQR)1 (0–7)2 (0–6)7
No. of hospital admissions in 1 year
 Mean ± SD1.17 ± 2.291.10 ± 1.953
 Median (IQR)0 (0–1)0 (−1)1
No. of emergency department visits in 1 year
 Mean ± SD4.58 ± 8.435.01 ± 6.436
 Median (IQR)2 (1–5)3 (1–7)29
No. of family physician visits in 1 year
 Mean ± SD21.05 ± 25.0722.78 ± 24.767
 Median (IQR)11 (5–27)13 (5–33)7
  • Note: HIV = human immunodeficiency virus, IQR = interquartile range, SD = standard deviation.

  • * Unless stated otherwise.

  • The standardized difference is the difference between group means expressed as a percentage of the pooled standard deviation. Standardized differences greater than 10% represent meaningful imbalances.

  • In accordance with ICES privacy policies, cell sizes ≤ 5 cannot be reported, and are instead expressed here as < 6.